|
Delayed
Japan Exchange
07:30:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 5,666.00 JPY | +0.16% |
|
-1.51% | +17.19% |
| 09-09 | Takeda Publishes Phase 3 Data Demonstrating Oveporexton Improves Narcolepsy Type 1 Symptoms | CI |
| 09-08 | Pharvaris' genetic disorder drug meets main goal in late-stage trial | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.16% | -1.51% | +1.87% | +12.58% | +17.19% | +25.80% | +24.66% | +51.62% | +21.38% | 58.64B | |
| -0.11% | -3.16% | -8.84% | -1.18% | +4.50% | +48.82% | +91.49% | +368.89% | +1,335.33% | 1,001B | |
| -0.27% | -4.34% | +1.73% | +11.68% | +28.70% | +51.52% | +65.89% | +59.52% | +125.28% | 642B | |
| +1.63% | -2.00% | +2.84% | +13.36% | +11.60% | +20.49% | +71.12% | +139.03% | +302.46% | 451B | |
| +0.12% | -3.39% | -6.51% | +6.03% | +5.09% | +28.50% | +35.84% | +0.95% | +44.31% | 340B | |
| +0.54% | -12.89% | -10.31% | -7.13% | +2.99% | +10.91% | +27.82% | +43.61% | +46.12% | 263B | |
| +0.14% | -1.90% | -0.56% | -13.26% | -14.60% | -1.49% | +12.14% | +45.43% | +142.43% | 247B | |
| -2.25% | -13.88% | -8.32% | +13.25% | +16.85% | +37.33% | +47.43% | +78.93% | +129.64% | 207B | |
| -3.05% | -6.83% | -9.34% | -1.43% | -14.37% | -19.49% | -59.28% | -11.55% | +86.72% | 197B | |
| -0.58% | -4.24% | +8.83% | +19.20% | +17.98% | +25.65% | +90.54% | +103.99% | +85.53% | 180B | |
| -0.47% | -4.03% | +2.22% | +8.01% | +11.04% | +12.54% | -19.27% | -39.35% | -18.91% | 158B | |
| -1.26% | -7.78% | -1.78% | +18.10% | +13.50% | +32.43% | +50.00% | +172.87% | +449.27% | 130B | |
| -1.02% | -6.37% | -1.68% | +14.66% | +18.19% | +35.21% | +4.82% | +0.98% | +14.53% | 130B | |
| -0.08% | -3.54% | -2.44% | -3.59% | -11.07% | -8.89% | -27.75% | -9.72% | +5.16% | 102B | |
| +0.14% | -3.66% | -6.17% | -9.35% | -2.49% | +17.23% | +21.12% | +0.55% | -10.60% | 96.24B | |
| +0.06% | -5.49% | -10.61% | -13.54% | -22.09% | -3.37% | +43.44% | +51.18% | +462.51% | 68.56B | |
| +0.20% | +0.02% | -0.18% | +36.52% | +32.02% | +69.48% | -4.57% | +6.39% | -47.77% | 55.63B | |
| -3.98% | -6.59% | -20.76% | -8.68% | -27.93% | -38.95% | +5.79% | -9.53% | +167.88% | 42.14B | |
| -1.36% | -0.74% | +0.58% | +8.25% | +16.47% | +85.74% | +277.86% | +295.54% | -27.60% | 42.36B | |
| -0.15% | -5.02% | -8.29% | +0.33% | -10.59% | -7.96% | +3.17% | - | - | 40.06B | |
| Average | -0.53% | -5.02% | -3.89% | +5.19% | +4.65% | +21.07% | +38.11% | +71.02% | +174.40% | 222.54B | |
| Weighted average by Cap. | -0.13% | -4.68% | -3.65% | +4.78% | +8.05% | +29.25% | +49.97% | +127.05% | +400.89% |
- Stock Market
- Stocks
- 4502 Stock
- Sector Takeda Pharmaceutical Company Limited
Select your edition
All financial news and data tailored to specific country editions
